(Q51452492)

5 April 2018

title

Congenital adrenal hyperplasia: an Indian experience. (English)

1 reference

5 April 2018

congenital adrenal hyperplasia

main subject

1 reference

Abhishek Maiti

1

1 reference

5 April 2018

Sudip Chatterjee

series ordinal

2

1 reference

5 April 2018

publication date

9 June 2011

1 reference

5 April 2018

Journal of Paediatrics and Child Health

published in

1 reference

5 April 2018

volume

47

1 reference

5 April 2018

issue

12

1 reference

5 April 2018

page(s)

883-887

1 reference

5 April 2018

Congenital adrenal hyperplasia.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Pregnancies in patients with congenital adrenal hyperplasia with complete or almost complete impairment of 21-hydroxylase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Management of the child with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Congenital adrenal hyperplasia in Sweden 1969-1986. Prevalence, symptoms and age at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Should we screen for congenital adrenal hyperplasia? A review of 117 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in the pre-screening era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Long-acting hydrocortisone for glucocorticoid replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Extraadrenal steroid 21-hydroxylation is not mediated by P450c21

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Extraadrenal 21-hydroxylation by CYP2C19 and CYP3A4: effect on 21-hydroxylase deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Extraadrenal formation of a mineralocorticosteroid: deoxycorticosterone and deoxycorticosterone sulfate biosynthesis and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Growth and reproductive outcomes in congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Adult Height and Fertility in Men with Congenital Virilizing Adrenal Hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

Lessons From 30 Years of Clinical Diagnosis and Treatment of Congenital Adrenal Hyperplasia in Five Middle European Countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1754.2011.02104.X

10.1111/J.1440-1754.2011.02104.X

21 January 2018

Identifiers

DOI

1 reference

5 April 2018

PubMed ID

21658148

1 reference

5 April 2018